# Anye Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anye-pharmaceutical

- Industry: Healthcare
- Headquarters: Shanghai, China
- Latest round: Series A (Aug 20, 2025)
- Investors on record: 1

## About

Founded in 2022 and based in Shanghai, China, Anye Pharmaceutical is a healthcare company focused on research and development of innovative therapies for neurological diseases. In August 2025, Anye Pharmaceutical raised a Series A funding from new invertor Guangdong Technology Venture Capital. The company concentrates on R&D of innovative therapies for nervous-system disorders, including projects described as small nucleic-acid drug interventions for conditions such as Angelman syndrome; its activities are described in public project listings and company registration summaries as biomedical/pharmaceutical research. The company's plausible revenue streams include R&D service contracts or collaborations with larger pharmas and institutions; licensing of intellectual property or technology transfer; government or grant funding for targeted biomedical projects; and future product sales or clinical-stage partnerships if candidate therapies advance.

## Funding rounds

- Series A, Aug 20, 2025 — Guangdong Technology Venture Capital

## Investors

- Guangdong Technology Venture Capital (https://capitalatlas.ai/funds/guangdong-technology-venture-capital) — Series A